FIGURE 2.

Kaplan–Meier curves for the proportion of participants with primary MN who progressed to the combined endpoint of complete or partial remission (A) or to complete remission considered as a single endpoint (B) in the subgroups of patients with anti-PLA₂R antibody titer above or below the median considered separately. The rate of progression to the combined endpoint was significantly higher in females than in males. The difference was significant even after adjusting for baseline serum creatinine levels. Similar but non-significant trends were observed for complete remission, considered as a single endpoint, even after adjustment for baseline serum creatinine levels.